[Treatment of acute coronary syndrome in a small volume center: "survival rate in hospital and at 2 years of follow up"]

Ann Cardiol Angeiol (Paris). 2007 Dec;56(6):303-7. doi: 10.1016/j.ancard.2007.09.009. Epub 2007 Oct 11.
[Article in French]

Abstract

We report our experience of the treatment of the coronary syndrome ST+ in a small volume center.

Patients and methods: For a period of 1 year (September 2004 to September 2005), 110 patients were treated by emergency coronarography at the hospital in Vichy (France). These patients were followed up for a period of 2 years.

Results: This population was relatively elderly: 43.6% of the patients were above 75 years of age. One hundred patients (91%) were treated by emergency angioplasty with a success rate of 88%. The average waiting time for treatment in the coronarography ward is 55 minutes and 35 seconds. Mortality in hospital is 6.36% for the totally of the population. It should be noted that 10.9% of these patients were admitted in a state of cardiogenic shock (12 patients), 3 of whom (25%) have died. 3 of these received a CPIA. At the end of an average follow-up of 21.44 months the survival rate is 83.6%, including and incident-free survival rate of 61.8%.

Conclusion: These results, comparable with what has been published in the literature, confirm the effectiveness of emergency coronary angioplasty as a method of revascularization even in a small volume center, in respect both of the survival rate in hospital and also of incident-free survival at 2 years.

Publication types

  • English Abstract

MeSH terms

  • Acute Coronary Syndrome / mortality
  • Acute Coronary Syndrome / therapy*
  • Adult
  • Aged
  • Aged, 80 and over
  • Angioplasty
  • Cause of Death
  • Coronary Angiography
  • Emergency Service, Hospital
  • Female
  • Fibrinolytic Agents / therapeutic use
  • Follow-Up Studies
  • France / epidemiology
  • Hospital Mortality
  • Humans
  • Male
  • Middle Aged
  • Patient Care Planning
  • Shock, Cardiogenic / mortality
  • Shock, Cardiogenic / therapy
  • Survival Rate
  • Treatment Outcome

Substances

  • Fibrinolytic Agents